Leonteq Securities’s Fusion Pharmaceuticals FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-35,000
Closed -$91K – 1307
2023
Q3
$91K Hold
35,000
– – 0.01% 672
2023
Q2
$164K Hold
35,000
– – 0.01% 574
2023
Q1
$132K Sell
35,000
-18,000
-34% -$70.9K 0.01% 600
2022
Q4
$167K Buy
+53,000
New +$132K 0.01% 574

Other funds holding FUSN

Leonteq Securities's FUSN Position: Q4 2023 in Review

Leonteq Securities sold out of Fusion Pharmaceuticals (FUSN) in Q4 2023, closing a stake of 35,000 shares — an estimated $91K sold.

Leonteq Securities first reported a position in FUSN in Q4 2022 and held it in 4 quarters. The position peaked at $167K in Q4 2022. 77 funds tracked by Wall St. Rank hold FUSN as of Q4 2023.

  • Leonteq Securities reported no remaining Fusion Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Leonteq Securities sold 35,000 Fusion Pharmaceuticals shares in Q4 2023, an estimated $91K.
  • Leonteq Securities first reported a position in Fusion Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Leonteq Securities's Fusion Pharmaceuticals position peaked at $167K in Q4 2022.
  • 77 funds tracked by Wall St. Rank held Fusion Pharmaceuticals as of Q4 2023.

Based on Leonteq Securities's 13F filing for Q4 2023, filed 11 Mar 2026.